Myricetin, a naturally occurring flavonoid, prevents 2-deoxy-d-ribose induced dysfunction and oxidative damage in osteoblastic MC3T3-E1 cells

European Journal of Pharmacology

Volumn 591, Issue 1-3, 2008, Pages 1-6

  Lee, Kyung Hee ^a   Choi, Eun Mi ^b  

^a Kyung Hee University   (South Korea)

^b Duksung Women's University   (South Korea)

Author keywords

2 Deoxy d ribose; Glucose toxicity; Myricetin; Oxidative stress

Indexed keywords

2 DEOXYRIBOSE; ALKALINE PHOSPHATASE; CALCIUM; COLLAGEN; MALONALDEHYDE; MYRICETIN; OSTEOCALCIN; OSTEOPROTEGERIN; PROTEIN DERIVATIVE;

ANIMAL CELL; ARTICLE; BONE DISEASE; CELL CULTURE; CELL LINE; CELL PROTECTION; CELL SURVIVAL; CONTROLLED STUDY; CULTURE MEDIUM; DIABETES MELLITUS; DIET SUPPLEMENTATION; DRUG EFFECT; ENZYME ACTIVITY; ENZYME INHIBITION; MOUSE; NONHUMAN; OSTEOBLAST; OXIDATIVE STRESS; PRIORITY JOURNAL;

ALKALINE PHOSPHATASE; ANIMALS; BONE DISEASES; CALCIUM; CELL LINE; CELL SURVIVAL; COLLAGEN; DEOXYRIBOSE; DIABETES COMPLICATIONS; DIETARY SUPPLEMENTS; FLAVONOIDS; MALONDIALDEHYDE; MICE; OSTEOBLASTS; OXIDATIVE STRESS; PROTEIN CARBONYLATION;

EID: 48749084360     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2008.06.004     Document Type: Article

References (34)

1. Bai X.C., Lu D., Bai J., Zheng H., Ke Z.Y., and Li X.M. Oxidative stress inhibits osteoblastic differentiation of bone cells by ERK and NF-kappaB. Biochem. Biophys. Res. Commun. 314 (2004) 197-207
2. Balint E., Szabo P., Marshall C.F., and Sprague S.M. Glucose-induced inhibition of in vitro bone mineralization. Bone (N.Y.) 28 (2001) 21-28
3. Benazzoug Y., Borchiellini C., Labat-Robert J., Robert L., and Kern P. Effect of high-glucose concentrations on the expression of collagens and fibronectin by fibroblasts in culture. Exp. Gerontol. 33 (1998) 445-455
4. Bi Y., Nielsen K.L., Kilts T.M., Yoon A., Karsdal M.A., Wimer H.F., Greenfield E.M., Heegaard A.M., and Young M.F. Biglycan deficiency increases osteoclast differentiation and activity due to defective osteoblasts. Bone 38 (2005) 778-786
5. Emancipator K. Laboratory diagnosis and monitoring of diabetes mellitus. Am. J. Clin. Pathol. 112 (1999) 665-674
6. Fatokun A.A., Stone T.W., and Smith R.A. Hydrogen peroxide-induced oxidative stress in MC3T3-E1 cells: the effects of glutamate and protection by purines. Bone 39 (2006) 542-551
7. Hamada Y., Kitazawa S., Kitazawa R., Fujii H., Kasuga M., and Fukagawa M. Histomorphometric analysis of diabetic osteopenia in streptozotocin-induced diabetic mice: a possible role of oxidative stress. Bone 40 (2007) 1408-1414
8. Herskind A.M., Christensen K., Norgaard-Andersen K., and Andersen J.F. Diabetes mellitus and healing of closed fractures. Diabetes Metab. 8 (1992) 63-64
9. Ihara Y., Toyokuni S., Uchida K., Odaka H., Tanaka T., Ikeda H., Hiai H., Seino Y., and Yamada Y. Hyperglycemia causes oxidative stress in pancreatic beta-cells of GK rats, a model of type 2 diabetes. Diabetes 48 (1999) 927-932
10. Ingram A.J., Ly H., Thai K., Kang M.J., and Scholey J.W. Mesangial cell signaling cascades in response to mechanical strain and glucose. Kidney Int. 56 (1999) 1721-1728
11. +)-ATPase activity reduction in high glucose-treated human erythrocytes. Free Radic. Biol. Med. 30 (2001) 222-237
12. Kanno S., Anuradha C.D., and Hirano S. Localization of zinc after in vitro mineralization in osteoblastic cells. Biol. Trace Elem. Res. 83 (2001) 39-47
13. Koh G., Suh K.S., Chon S., Oh S., Woo J.T., Kim S.W., Kim J.W., and Kim Y.S. Elevated cAMP level attenuates 2-deoxy-d-ribose-induced oxidative damage in pancreatic b-cells. Arch. Biochem. Biophys. 438 (2005) 70-79
14. Krakauer J., McKenna M., Burderer N., Rao D., Whitehouse F., and Pafitt A. Bone loss and bone turnover in diabetes. Diabetes 44 (1995) 775-782
15. Kuo P.L. Myricetin inhibits the induction of anti-Fas IgM-, tumor necrosis factor-alpha- and interleukin-1beta-mediated apoptosis by Fas pathway inhibition in human osteoblastic cell line MG-63. Life Sci. 77 (2005) 2964-2976
16. Levine R.L., Williams J.A., Stadtman E.R., and Shacter E. Carbonyl assays for determination of oxidatively modified proteins. Meth. Enzymol. 233 (1994) 346-363
17. Lopez-Ibarra P.J., Pastor M.M., Escobar-Jimenez F., Pardo M.D., Gonzalez A.G., and Luna J.D. Bone mineral density at time of clinical diagnosis of adult-onset type 1 diabetes mellitus. Endocr. Pract. 7 (2001) 346-351
18. Manduteanu I., Voinea M., Serban G., and Simionescu M. High glucose induces enhanced monocyte adhesion to valvular endothelial cells via a mechanism involving ICAM-1, VCAM-1 and CD18. Endothelium 6 (1999) 315-324
19. Marini M., Zunica G., and Franceschi C. Inhibition of cell proliferation by d-ribose and deoxy-d-ribose. Proc. Soc. Exp. Biol. Med. 180 (1985) 246-257
20. Matsuoka T., Kajimoto Y., Watada H., Kaneto H., Kishimoto M., Umayahara Y., Fujitani Y., Kamada T., Kawamori R., and Yamasaki Y. Glycation-dependent, reactive oxygen species-mediated suppression of the insulin gene promoter activity in HIT cells. J. Clin. Invest. 99 (1997) 144-150
21. McNair P., Madsbad S., Christensen M.S., Christiansen C., Faber O.K., Binder C., and Transbol I. Bone mineral loss in insulin-treated diabetes mellitus: studies on pathogenesis. Acta Endocrinol. (Copenh) 90 (1979) 463-472
22. Molina-Jimenez M.F., Sanchez-Reus M.I., Andres D., Cascales M., and Benedi J. Neuroprotective effect of fraxetin and myricetin against rotenone-induced apoptosis in neuroblastoma cells. Brain Res. 1009 (2004) 9-16
23. Monnier V.M. Nonenzymatic glycosylation, the Maillard reaction and the aging process. J. Gerontol. 45 (1990) B105-118
24. Mullarkey C.J., Edelstein D., and Brownlee M. Free radical generation by early glycation products: a mechanism for accelerated atherogenesis in diabetes. Biochem. Biophys. Res. Commun. 173 (1990) 932-939
25. Ong K.C., and Khoo H.E. Insulinomimetic effects of myricetin on lipogenesis and glucose transport in rat adipocytes but not glucose transport. Biochem. Pharmacol. 51 (1996) 423-429
26. Ong K.C., and Khoo H.E. Effects of myricetin on glycemia and glycogen metabolism in diabetic rats. Life Sci. 67 (2000) 1695-1705
27. Robertson R.P. Chronic oxidative stress as a central mechanism for glucose toxicity in pancreatic islet beta cells in diabetes. J. Biol. Chem. 279 (2004) 42351-42354
28. Sitte N., Huber M., Grune T., Ladhoff A.M., Doecke W.D., Zglinicki T., and Davies K.J.A. Proteasome inhibition by lipofuscin/ceroid during postmitotic aging fibroblasts. FASEB J. 14 (2001) 1490-1498
29. Teissedre P.L., Frankel E.N., Waterhouse A.L., Peleg H., and German J.B. Inhibition of in vitro human LDL oxidation by phenolic antioxidants from grapes and wines. J. Sci. Food Agric. 70 (1996) 55-61
30. Tilton R.G., Chang K., Nyengaard J.R., Van den Enden M., Ido Y., and Williamson J.R. Inhibition of sorbitol dehydrogenase. Effects on vascular and neural dysfunction in streptozocin-induced diabetic rats. Diabetes 44 (1995) 234-242
31. Williamson J.R., Chang K., Frangos M., Hasan K.S., Ido Y., Kawamura T., Nyengaard J.R., van den Enden M., Kilo C., and Tilton R.G. Hyperglycemic pseudohypoxia and diabetic complications. Diabetes 42 (1993) 801-813
32. Witko-Sarsat V., Friedlander M., Capeillere-Blandin C., Nguyen-Khoa T., Nguyen A.T., and Zingraff J. Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int. 49 (1996) 1304-1313
33. Yang S.F., Wu Q., Sun A.S., Huang X.N., and Shi J.S. Protective effect and mechanism of Ginkgo biloba leaf extracts for Parkinson disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Acta Pharmacol. Sin. 22 (2001) 1089-1093
34. Zayzafoon M., Stell C., Irwin R., and McCabe L.R. Extracellular glucose influences osteoblast differentiation and c-Jun expression. J. Cell. Biochem. 79 (2000) 301-310